Neuropeptide Y (NPY) receptors are involved in different types of biological processes. It is a class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake; however the topic is still a part of extensive medical research.
Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.
Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
In 2019, the market size of Neuropeptide Y Receptor is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Neuropeptide Y Receptor.
This report studies the global market size of Neuropeptide Y Receptor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Neuropeptide Y Receptor production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Gila Therapeutics
Novo Nordisk
XL-protein
Lilly Eli
Novartis
Pfizer
Merck & Co
Mannkind
Gilead Sciences
Genentech
Market Segment by Product Type
Food Grade
Pharmaceutical Grade
Market Segment by Application
Medicine
Food Additives
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Neuropeptide Y Receptor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Neuropeptide Y Receptor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Neuropeptide Y Receptor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Neuropeptide Y Receptor . Industry analysis & Market Report on Neuropeptide Y Receptor is a syndicated market report, published as Global (United States, European Union and China) Neuropeptide Y Receptor Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Neuropeptide Y Receptor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.